New gene responsible for cleft lip and palate syndrome identified
An international team led by researchers from Karolinska Institutet in Sweden has identified a new gene related to the Van der Woude syndrome, the most common syndrome with cleft lip and palate. The study is published in the scientific periodical American Journal of Human Genetics and can lead the way to improved genetic diagnostic of individuals and families with orofacial clefts.
Cleft lip and palate is one of the most common birth defects and can be found in the form of cleft lip or cleft palate alone; or cleft lip and palate together. They may occur together with other malformations, forming a syndrome. There are more than 350 syndromes with clefts, of which Van der Woude syndrome (VWS) is the most common. Approximately 70 per cent of the individuals with VWS have a mutation in a gene called interferon regulatory factor 6 (IRF6).
Now, through an international collaboration between researchers from Sweden, USA, Finland and Israel, a second gene related to VWS has been found. The researchers started by doing a so called genetic linkage study of a large family from Finland. The family had been diagnosed with VWS, albeit no IRF6 mutations had been found. By comparing the DNA of affected individuals with DNA from healthy family members, the researchers identified another gene, called Grainy-head like 3 (GRHL3), which was mutated only in the affected family members. The same gene was found to be altered in 7 additional families with VWS where no IRF6 mutations had been found previously.
”The discovery of a new gene, GRHL3, responsible for the most common of the syndromic forms of cleft lip and palate means that researcher or clinicians with collections of families or isolated cases with cleft lip and palate, syndromic or non-syndromic, now will be able to look for mutations in this gene”, says Dr Myriam Peyrard-Janvid at the Department of Biosciences and Nutrition, Karolinska Institutet, who led this large collaborative study. ”As it has been shown for IRF6, one or several polymorphisms in GRHL3 might be found to be associated with increased risk of clefts in non-syndromic cases.”
To further investigate the role of GRHL3 in oral abnormalities, six laboratories collaborated and studied human mutations of the gene in zebrafish and mouse models. They found that mouse embryos lacking GRHL3 cannot form a proper palate and are born with a cleft. GRHL3 encodes a transcription factor that is itself regulated by IRF6. The authors conclude that both genes are required for a proper formation of the palate, probably functioning in separate but convergent molecular pathways. The study highlights the importance of studying even rare patients to increase our understanding of disease mechanisms.
The research conducted at Karolinska Institutet was supported financially by the Swedish Research Council and the Sigrid Jusélius Foundation.
Publication: ”Dominant mutations in GRHL3 cause Van der Woude syndrome and disrupt oral periderm Development”, Myriam Peyrard-Janvid, Elizabeth J. Leslie, Youssef A. Kousa, Tiffany L. Smith, Martine Dunnwald, Måns Magnusson, Brian A. Lentz, Per Unneberg, Ingegerd Fransson, Hannele K. Koillinen, Jorma Rautio, Marie Pegelow, Agneta Karsten, Lina Basel-Vanagaite, William Gordon Bogi Andersen, Thomas Svensson, Jeffrey C. Murray, Robert A. Cornell, Juha Kere, and Brian C. Schutte, American Journal of Human Geneticsx, online ahead of print 19 December 2013, publishing in the January 02, 2014 issue.
Contacts
For further information, please contact:
Myriam Peyrard-Janvid, PhD
Department of Biosciences and Nutrition, Karolinska Institutet
Phone: +46 08 524 810 26 or +46 0708 345423
Email: myriam.peyrard@ki.se
Juha Kere, Professor
Department of Biosciences and Nutrition, Karolinska Institutet
Phone: +46 08 524 810 57 or +46 0734213550
Email juha.kere@ki.se
Contact the Press Office and download images (http://ki.se/pressroom)
Karolinska Institutet (http://ki.se/english) is one of the world’s leading medical universities. It accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Subscribe to releases from Karolinska Institutet - English
Subscribe to all the latest releases from Karolinska Institutet - English by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Karolinska Institutet - English
New method reveals how the brain and inner ear are formed3.4.2025 20:00:00 CEST | Pressmeddelande
Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo. By labelling stem cells with a genetic ‘barcode’, they have been able to follow the cells’ developmental journey and discover how the inner ear is formed in mice. The discovery, published in Science, could provide important insights for future treatment of hearing loss.
Fluoride in drinking water is associated with impaired childhood cognition7.3.2025 15:30:00 CET | Pressmeddelande
Elevated concentrations of fluoride can occur in well water, and in some countries, it is added to drinking water to counteract caries in the population. A study from Karolinska Institutet in Sweden now supports a few previous studies indicating that exposure to fluoride during the fetal stage or early childhood may impair cognition in children. The study is published in the journal Environmental Health Perspectives.
Children with ARFID face increased risk of disease17.2.2025 17:00:00 CET | Pressmeddelande
Children with avoidant restrictive food intake disorder (ARFID) have an elevated risk of developing psychiatric and physical conditions, a new study from Karolinska Institutet published in JAMA Pediatrics reports. The study highlights the importance of early identification to improve care of these children.
Preterm babies receive insufficient pain management27.1.2025 15:29:17 CET | Pressmeddelande
A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown by the largest survey to date of pain in neonatal care, now published in the journal Pain.
New study paves way for immunotherapies tailored for childhood cancers20.1.2025 17:00:00 CET | Pressmeddelande
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom